| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.0B | $5.8B | $5.5B | $5.9B | $5.6B | $1.1B | $1.1B | $1.2B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.5B | $1.5B | $1.3B | $1.3B | $1.4B | $0.2B | $0.2B | $0.2B |
| Net Income | $0.9B | $0.9B | $0.7B | $0.8B | $0.9B | $0.1B | $0.1B | $0.0B |
| EPS (Basic) | $3.71 | $3.79 | $3.18 | $3.27 | $3.84 | $2.72 | $2.80 | $2.50 |
| EPS (Diluted) | $3.66 | $3.79 | $3.17 | $3.27 | $3.83 | $2.72 | $2.79 | $2.50 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $33.9B | $32.3B | $31.0B | $29.5B | $28.5B | $27.1B | $26.0B | $25.6B |
| Current Assets | $1.8B | $1.8B | $1.8B | $1.8B | $1.7B | $1.6B | $1.5B | $1.7B |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.0B | $0.2B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $3.7B | $3.7B | $3.5B | $3.5B | $3.1B | $2.4B | $2.3B | $2.9B |
| Stockholders' Equity | $10.2B | $10.0B | $9.7B | $9.5B | $9.2B | $8.7B | $8.6B | $10.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.0B | $2.0B | $2.0B | $1.8B | $1.4B | $1.8B | $1.7B | $1.5B |
| Investing Cash Flow | $-2.6B | $-2.3B | $-2.5B | $-2.2B | $-1.9B | $-1.5B | $-1.1B | $0.2B |
| Capital Expenditures | $2.8B | $2.3B | $2.3B | $2.2B | $2.0B | $1.6B | $1.2B | $1.1B |
| Financing Cash Flow | $0.5B | $0.3B | $0.5B | $0.3B | $0.4B | $-0.1B | $-0.8B | $-1.5B |